AZT triphosphate (3'-Azido-3'-deoxytmidine-5'-triphosphate) tetraammonium is an active triphosphate metabolite of Zidovudine (AZT). AZT triphosphate tetraammonium exhibits antiretroviral activity and inhibits replication of apoptosis pathway[1][2][3].
AZT triphosphate (3'-Azido-3'-deoxytmidine-5'-triphosphate) tetraammonium 通过用 100 µM Zidovudine (AZT) 处理 48 小时进行积累破坏 H9c2 细胞中的线粒体管状网络。 AZT triphosphate tetraammonium 积累导致 Opa1 的下调和 Drp1 的上调。 AZT triphosphate tetraammonium 导致大鼠胚胎成肌细胞 H9c2 细胞模型线粒体功能障碍,增加细胞毒性活性氧 (ROS) 的产生,并损害线粒体质量控制系统的平衡[1]。
[1]. Ryosuke Nomura, et al. Azidotmidine-triphosphate Impairs Mitochondrial Dynamics by Disrupting the Quality Control System. Redox Biol. 2017 Oct;13:407-417.
[2]. Takeya Sato, et al. Engineered Human tmpk/AZT as a Novel Enzyme/Prodrug Axis for Suicide Gene Therapy. Mol Ther. 2007 May;15(5):962-70.
[3]. K Y Hostetler, et al. Enhanced Oral Absorption and Antiviral Activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and Related Compounds in Hepatitis B Virus Infection, in Vitro. Biochem Pharmacol. 1997 Jun 15;53(12):1815-22.
















